PPARGC1A (Q9UBK2) variants and mutations
PPARGC1A (also known as Q9UBK2) is a human protein-coding gene encoding a peroxisome proliferator-activated receptor gamma coactivator 1-alpha protein. It coactivates transcriptional programs for mitochondrial biogenesis, oxidative metabolism, thermogenesis, and endurance adaptation. Altered activity is implicated in metabolic, cardiovascular, and neurodegenerative disease, although highly penetrant monogenic disorders are uncommon. This analysis covers 1,146 PPARGC1A variants and mutations. Of these, 83% have computational variant effect predictions. Disease context includes heart conduction disease, Left bundle branch block, and amyotrophic lateral sclerosis. Example PPARGC1A variants include A2V, W3L, and W3R.
Variant analysis overview
- Gene: PPARGC1A
- Protein: Q9UBK2
- UniProt accession: Q9UBK2
- Organism: Homo sapiens
- Variants analyzed: 1146
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 953 unspecified-consequence records; 1 stop retained variant; 87 synonymous variants; 87 missense variants; 8 frameshift variants; 2 stop-gained variants; 2 splice-region variants; 1 in-frame deletions; 4 substitution
- Prediction scores: 955 variants have prediction scores (83% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: heart conduction disease, Left bundle branch block, amyotrophic lateral sclerosis, placenta praevia, smoking initiation, Complete right bundle branch block, conduction system disorder, bundle branch block, kidney failure, neurodegenerative disease, schizophrenia, Abnormality of the skeletal system.
Protein structure and variant hotspots
- Protein features: 1 domains; 15 post-translational modification sites.
- Structural context: 165 variants have structural context.
- PTM context: 17 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable PPARGC1A variants
Examples include A2V, W3L, W3R, D4N, D4V, M5K, M5T, C6G. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2V (p.Ala2Val), rs771290152, NCI-TCGA Cosmic COSV9933, cosmic curated COSV99337, ExAC rs771290152, REVEL 0.35, CADD 31.00, Variant assessed as somatic; moderate impact.
- W3L (p.Trp3Leu), Ensembl rs70937062
- W3R (p.Trp3Arg), rs981976152, ClinGen CA94205212, ClinVar RCV004111787, Ensembl rs981976152, REVEL 0.42, CADD 31.00, Uncertain significance, not specified
- D4N (p.Asp4Asn), ExAC rs761253295, gnomAD rs761253295, REVEL 0.22, CADD 25.10
- D4V (p.Asp4Val), NCI-TCGA Cosmic COSV9933, cosmic curated COSV99338, MetaLR 0.17, MetaSVM -0.86, Variant assessed as somatic; moderate impact.
- M5K (p.Met5Lys), rs773095749, ClinGen CA356608003, ClinVar RCV003896562, NCI-TCGA Cosmic COSV5353, AlphaMissense 0.30, MetaLR 0.06, Uncertain significance, PPARGC1A-related disorder
- M5T (p.Met5Thr), ExAC rs773095749, TOPMed rs773095749, gnomAD rs773095749, MetaLR 0.04, MetaSVM -1.11
- C6G (p.Cys6Gly), Ensembl rs1717575962, MetaLR 0.14, MetaSVM -0.95
- C6Y (p.Cys6Tyr), TOPMed rs1717575448, REVEL 0.42, CADD 27.30
- N7K (p.Asn7Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N7S (p.Asn7Ser), ExAC rs772131746, TOPMed rs772131746, gnomAD rs772131746, REVEL 0.15, CADD 22.70
- Q8K (p.Gln8Lys), Ensembl rs1717573871
- Q8P (p.Gln8Pro), rs2476512400, ClinGen CA356607979, ClinVar RCV004271217, Uncertain significance, not specified
- D9E (p.Asp9Glu), Ensembl rs970647152, REVEL 0.12, CADD 25.60
- S10F (p.Ser10Phe), Ensembl rs1717572915, MetaLR 0.06, MetaSVM -1.03
- S10G (p.Ser10Gly), rs933778371, []
- E11G (p.Glu11Gly), ESP rs372189559, ExAC rs372189559, TOPMed rs372189559, gnomAD rs372189559, REVEL 0.03, CADD 22.90
- E11Q (p.Glu11Gln), Ensembl rs1577672162, REVEL 0.18, CADD 22.70
- V13A (p.Val13Ala), TOPMed rs1717570585, REVEL 0.24, CADD 25.20
- D16A (p.Asp16Ala), Ensembl rs2148852946, REVEL 0.18, CADD 25.70
- I17M (p.Ile17Met), ExAC rs768910116, TOPMed rs768910116, gnomAD rs768910116, REVEL 0.21, CADD 25.00
- C19Y (p.Cys19Tyr), TOPMed rs1406929929, gnomAD rs1406929929, REVEL 0.38, CADD 31.00
- A21T (p.Ala21Thr), Ensembl rs1716603226
- L22P (p.Leu22Pro), TOPMed rs1716602667, gnomAD rs1716602667, REVEL 0.40, CADD 28.60
- D26A (p.Asp26Ala), Ensembl rs1577654838
- D26Y (p.Asp26Tyr), NCI-TCGA Cosmic COSV9933, cosmic curated COSV99338, Variant assessed as somatic; moderate impact.
- Q27H (p.Gln27His), TOPMed rs1716600627, REVEL 0.35, CADD 25.30
- P28H (p.Pro28His), NCI-TCGA TCGA novel, MetaLR 0.18, MetaSVM -0.93, Variant assessed as somatic; moderate impact.
- L29I (p.Leu29Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D32E (p.Asp32Glu), TOPMed rs1264002788, gnomAD rs1264002788, REVEL 0.31, CADD 25.30
- D32H (p.Asp32His), ExAC rs757290172, TOPMed rs757290172, gnomAD rs757290172, REVEL 0.42, CADD 26.20
- P34L (p.Pro34Leu), NCI-TCGA Cosmic COSV5352, cosmic curated COSV53526, Variant assessed as somatic; moderate impact.
- P34S (p.Pro34Ser), gnomAD rs1716597875, REVEL 0.49, CADD 27.50
- L36I (p.Leu36Ile), ExAC rs751064415, gnomAD rs751064415, REVEL 0.20, CADD 23.50
- D37A (p.Asp37Ala), TOPMed rs1315540191, gnomAD rs1315540191, REVEL 0.53, CADD 24.90
- D37E (p.Asp37Glu), Ensembl rs1716596094
- L38V (p.Leu38Val), NCI-TCGA Cosmic COSV5353, cosmic curated COSV53533, REVEL 0.33, CADD 25.80, Variant assessed as somatic; moderate impact.
- S39C (p.Ser39Cys), NCI-TCGA Cosmic COSV5352, cosmic curated COSV53526, Variant assessed as somatic; moderate impact.
- E40* (p.Glu40Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- L41R (p.Leu41Arg), Ensembl rs1404820197
- V43A (p.Val43Ala), ExAC rs777438884, gnomAD rs777438884, REVEL 0.31, CADD 23.50
- V43M (p.Val43Met), Ensembl rs1469800816, REVEL 0.35, CADD 26.10
- N44K (p.Asn44Lys), TOPMed rs897201437, gnomAD rs897201437, Likely benign
- N44S (p.Asn44Ser), TOPMed rs994022617, gnomAD rs994022617, REVEL 0.12, CADD 22.40
- N44T (p.Asn44Thr), TOPMed rs994022617, gnomAD rs994022617, MetaLR 0.14, MetaSVM -0.94
- D45H (p.Asp45His), ExAC rs752387695, TOPMed rs752387695, gnomAD rs752387695, REVEL 0.42, CADD 26.20
- D45N (p.Asp45Asn), ExAC rs752387695, TOPMed rs752387695, gnomAD rs752387695, REVEL 0.37, CADD 26.60
- L46V (p.Leu46Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T48R (p.Thr48Arg), TOPMed rs1716590834, REVEL 0.32, CADD 23.90
- D49N (p.Asp49Asn), gnomAD rs1382820228, REVEL 0.23, CADD 23.80
- S50C (p.Ser50Cys), gnomAD rs1338326192, REVEL 0.20, CADD 25.00
- F51L (p.Phe51Leu), gnomAD rs1422031469, REVEL 0.33, CADD 24.80
- G53C (p.Gly53Cys), TOPMed rs971433900, gnomAD rs971433900, REVEL 0.36, CADD 26.50
- L55F (p.Leu55Phe), TOPMed rs1331117896
- L55P (p.Leu55Pro), ExAC rs761081409, gnomAD rs761081409
- W57* (p.Trp57Ter), NCI-TCGA Cosmic COSV9933, cosmic curated COSV99337, Variant assessed as somatic; high impact.
- W57R (p.Trp57Arg), TOPMed rs1437966460, REVEL 0.57, CADD 28.80, Uncertain significance, not specified
- S59G (p.Ser59Gly), cosmic curated COSV10636, ExAC rs750797347, gnomAD rs750797347, REVEL 0.24, CADD 23.70
- S59R (p.Ser59Arg), ExAC rs750797347, gnomAD rs750797347, REVEL 0.31, CADD 24.40
- D60V (p.Asp60Val), Ensembl rs201750508
- S62A (p.Ser62Ala), gnomAD rs1383314837, REVEL 0.28, CADD 24.20
- E63* (p.Glu63Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- I64M (p.Ile64Met), TOPMed rs1013368919, gnomAD rs1013368919, REVEL 0.26, CADD 16.20
- I64V (p.Ile64Val), rs1280883830, ClinGen CA356607355, ClinVar RCV004141474, TOPMed rs1280883830, AlphaMissense 0.09, MetaLR 0.06, Uncertain significance, not specified
- I65T (p.Ile65Thr), ExAC rs767975424, gnomAD rs767975424, REVEL 0.26, CADD 22.60
- S66A (p.Ser66Ala), TOPMed rs1017037521, gnomAD rs1017037521, REVEL 0.18, CADD 23.30
- S66F (p.Ser66Phe), rs1259694270, NCI-TCGA Cosmic COSV5353, TOPMed rs1259694270, gnomAD rs1259694270, REVEL 0.41, CADD 26.80, Variant assessed as somatic; moderate impact.
- S66P (p.Ser66Pro), TOPMed rs1017037521, gnomAD rs1017037521
- S66T (p.Ser66Thr), TOPMed rs1017037521, gnomAD rs1017037521
- N67K (p.Asn67Lys), cosmic curated COSV10878, NCI-TCGA TCGA novel, MetaLR 0.07, MetaSVM -0.93, Variant assessed as somatic; moderate impact.
- N67S (p.Asn67Ser), gnomAD rs1716580039, REVEL 0.09, CADD 16.00
- Q68* (p.Gln68Ter), NCI-TCGA Cosmic COSV9933, cosmic curated COSV99338, Variant assessed as somatic; high impact.
- Q68K (p.Gln68Lys), NCI-TCGA Cosmic COSV9933, cosmic curated COSV99337, Variant assessed as somatic; moderate impact.
- N71S (p.Asn71Ser), TOPMed rs1337237971, gnomAD rs1337237971, REVEL 0.07, CADD 19.30
- P73T (p.Pro73Thr), TOPMed rs1194231522, REVEL 0.11, CADD 20.70
- S74L (p.Ser74Leu), cosmic curated COSV53529, 1000Genomes rs142669571, ESP rs142669571, ExAC rs142669571, REVEL 0.26, CADD 24.90
- I76T (p.Ile76Thr), ExAC rs763011793, gnomAD rs763011793, MetaLR 0.13, MetaSVM -0.98
- K79T (p.Lys79Thr), ExAC rs779748979, MetaLR 0.18, MetaSVM -0.78
- I80T (p.Ile80Thr), ExAC rs751972617, gnomAD rs751972617, REVEL 0.26, CADD 25.70
- I80V (p.Ile80Val), rs757606579, NCI-TCGA Cosmic COSV9933, cosmic curated COSV99337, ExAC rs757606579, REVEL 0.17, CADD 23.80, Variant assessed as somatic; moderate impact.
- E83D (p.Glu83Asp), TOPMed rs1312484686, gnomAD rs1312484686
- E83G (p.Glu83Gly), Ensembl rs879094844
- N84I (p.Asn84Ile), NCI-TCGA Cosmic COSV9933, cosmic curated COSV99338, Variant assessed as somatic; moderate impact.
- E85D (p.Glu85Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A86P (p.Ala86Pro), ESP rs370930722, ExAC rs370930722, TOPMed rs370930722, gnomAD rs370930722, REVEL 0.37, CADD 25.60
- A86T (p.Ala86Thr), ESP rs370930722, ExAC rs370930722, TOPMed rs370930722, gnomAD rs370930722, REVEL 0.25, CADD 25.20
- A90E (p.Ala90Glu), gnomAD rs1304824586, REVEL 0.48, CADD 26.50
- A90P (p.Ala90Pro), Ensembl rs2109700984
- A90V (p.Ala90Val), gnomAD rs1304824586, REVEL 0.41, CADD 32.00
- V91D (p.Val91Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V91I (p.Val91Ile), ExAC rs752763867, gnomAD rs752763867
- T93A (p.Thr93Ala), TOPMed rs1003607952
- E94D (p.Glu94Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E94K (p.Glu94Lys), Ensembl rs2109700712
- T95K (p.Thr95Lys), ExAC rs759753596, gnomAD rs759753596, REVEL 0.42, CADD 26.70
- D97E (p.Asp97Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- D97N (p.Asp97Asn), NCI-TCGA Cosmic COSV5352, cosmic curated COSV53525, REVEL 0.31, CADD 26.30, Variant assessed as somatic; moderate impact.
- S98R (p.Ser98Arg), ExAC rs754095698, gnomAD rs754095698, REVEL 0.33, CADD 26.60
- L99I (p.Leu99Ile), ExAC rs766754022, gnomAD rs766754022, REVEL 0.11, CADD 17.40
- D102V (p.Asp102Val), rs1419054523, gnomAD rs1419054523, REVEL 0.48, CADD 27.50, Variant assessed as somatic; moderate impact.
- D102Y (p.Asp102Tyr), ExAC rs773174815, gnomAD rs773174815, REVEL 0.47, CADD 26.40
- E103K (p.Glu103Lys), TOPMed rs1381870292, gnomAD rs1381870292, REVEL 0.36, CADD 27.30
- D104E (p.Asp104Glu), NCI-TCGA Cosmic COSV5353, cosmic curated COSV53534, Variant assessed as somatic; moderate impact.
- D104H (p.Asp104His), ExAC rs772000021, gnomAD rs772000021, REVEL 0.35, CADD 26.00
- D104Y (p.Asp104Tyr), ExAC rs772000021, gnomAD rs772000021
- G105R (p.Gly105Arg), TOPMed rs1157278042, REVEL 0.44, CADD 26.60, Uncertain significance, not specified
- G105V (p.Gly105Val), NCI-TCGA Cosmic COSV5352, cosmic curated COSV53529, Variant assessed as somatic; moderate impact.
- P107H (p.Pro107His), ExAC rs773848879, gnomAD rs773848879, REVEL 0.43, CADD 27.10
- P107L (p.Pro107Leu), cosmic curated COSV53532, ExAC rs773848879, gnomAD rs773848879, REVEL 0.46, CADD 28.00
- D110H (p.Asp110His), ESP rs374705115, ExAC rs374705115, gnomAD rs374705115
- A111E (p.Ala111Glu), 1000Genomes rs779660669, ExAC rs779660669, TOPMed rs779660669, gnomAD rs779660669
- A111V (p.Ala111Val), rs779660669, NCI-TCGA Cosmic COSV9933, cosmic curated COSV99337, 1000Genomes rs779660669, REVEL 0.35, CADD 24.80, Variant assessed as somatic; moderate impact.
- T113A (p.Thr113Ala), cosmic curated COSV99338, Ensembl rs1725023508, REVEL 0.24, CADD 22.70
- T113R (p.Thr113Arg), TOPMed rs1725023043
- D114G (p.Asp114Gly), 1000Genomes rs200320648, ExAC rs200320648, TOPMed rs200320648, gnomAD rs200320648, REVEL 0.34, CADD 25.10
- G115E (p.Gly115Glu), NCI-TCGA Cosmic COSV5353, cosmic curated COSV53532, Variant assessed as somatic; moderate impact.
- G115R (p.Gly115Arg), rs769083394, ClinGen CA2875553, cosmic curated COSV10806, ClinVar RCV004070980, REVEL 0.35, CADD 24.00, Uncertain significance, not specified
- D116E (p.Asp116Glu), ExAC rs529427617, TOPMed rs529427617, gnomAD rs529427617, REVEL 0.17, CADD 23.90
- D116N (p.Asp116Asn), TOPMed rs1449112921, gnomAD rs1449112921, REVEL 0.23, CADD 24.20
- V117L (p.Val117Leu), ExAC rs754009449, gnomAD rs754009449, REVEL 0.31, CADD 23.50
- V117M (p.Val117Met), rs754009449, NCI-TCGA Cosmic COSV5352, cosmic curated COSV53524, ExAC rs754009449, REVEL 0.32, CADD 24.00, Variant assessed as somatic; moderate impact.
- T118A (p.Thr118Ala), NCI-TCGA Cosmic COSV9933, cosmic curated COSV99337, Variant assessed as somatic; moderate impact.
- T118P (p.Thr118Pro), Ensembl rs1725018880
- T119A (p.Thr119Ala), TOPMed rs1312379626
- D120E (p.Asp120Glu), ExAC rs766670450, TOPMed rs766670450, gnomAD rs766670450, REVEL 0.07, CADD 15.60
- N121S (p.Asn121Ser), gnomAD rs1404591551, REVEL 0.18, CADD 17.10
- A123D (p.Ala123Asp), NCI-TCGA Cosmic COSV5353, Variant assessed as somatic; moderate impact.
- A123V (p.Ala123Val), NCI-TCGA Cosmic COSV5353, cosmic curated COSV53534, Variant assessed as somatic; moderate impact.
- S124G (p.Ser124Gly), ExAC rs767224331, TOPMed rs767224331, gnomAD rs767224331, REVEL 0.27, CADD 24.40
- S124R (p.Ser124Arg), ExAC rs767224331, TOPMed rs767224331, gnomAD rs767224331
- P125L (p.Pro125Leu), ExAC rs761735360, gnomAD rs761735360, REVEL 0.03, CADD 22.70
- S126F (p.Ser126Phe), NCI-TCGA Cosmic COSV5352, NCI-TCGA Cosmic COSV9933, cosmic curated COSV99337, REVEL 0.23, CADD 27.60, Variant assessed as somatic; moderate impact.
- S126Y (p.Ser126Tyr), NCI-TCGA Cosmic COSV5352, cosmic curated COSV53527, NCI-TCGA Cosmic COSV9933, Variant assessed as somatic; moderate impact.
- S127C (p.Ser127Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- M128I (p.Met128Ile), NCI-TCGA Cosmic COSV9933, cosmic curated COSV99337, Variant assessed as somatic; moderate impact.
- M128V (p.Met128Val), ExAC rs747541869, gnomAD rs747541869, MetaLR 0.03, MetaSVM -1.06
- P129S (p.Pro129Ser), NCI-TCGA Cosmic COSV9933, cosmic curated COSV99338, MetaLR 0.25, MetaSVM -0.63, Variant assessed as somatic; moderate impact.
- D130V (p.Asp130Val), cosmic curated COSV53530, Ensembl rs1577431581, REVEL 0.20, CADD 26.50
- G131C (p.Gly131Cys), TOPMed rs933778371, gnomAD rs933778371
- G131D (p.Gly131Asp), cosmic curated COSV53531, ExAC rs762420400, gnomAD rs762420400, REVEL 0.30, CADD 23.30
- G131R (p.Gly131Arg), TOPMed rs933778371, gnomAD rs933778371
- G131S (p.Gly131Ser), cosmic curated COSV53533, TOPMed rs933778371, gnomAD rs933778371, REVEL 0.27, CADD 24.10, Uncertain significance, not specified
- T132I (p.Thr132Ile), ExAC rs775001167, gnomAD rs775001167, REVEL 0.20, CADD 23.90
- T132N (p.Thr132Asn), ExAC rs775001167, gnomAD rs775001167, MetaLR 0.14, MetaSVM -1.07
- P133L (p.Pro133Leu), gnomAD rs1351048482, REVEL 0.37, CADD 24.40
- P134L (p.Pro134Leu), TOPMed rs1288109429, gnomAD rs1288109429, REVEL 0.23, CADD 24.10
- P134S (p.Pro134Ser), TOPMed rs1176393141, gnomAD rs1176393141, REVEL 0.23, CADD 24.20
- P135L (p.Pro135Leu), TOPMed rs1243632497, gnomAD rs1243632497, REVEL 0.11, CADD 22.70
- Q136* (p.Gln136Ter), TOPMed rs1379682024, gnomAD rs1379682024, CADD 37.00, Uncertain significance
- Q136K (p.Gln136Lys), rs1379682024, ClinGen CA356602222, ClinVar RCV004233270, TOPMed rs1379682024, REVEL 0.20, CADD 25.60, Uncertain significance, not specified
- E137D (p.Glu137Asp), Ensembl rs2109698498, REVEL 0.16, CADD 25.20
- E137K (p.Glu137Lys), gnomAD rs1358609848, REVEL 0.35, CADD 26.20
- A138S (p.Ala138Ser), ExAC rs769377888, TOPMed rs769377888, gnomAD rs769377888, REVEL 0.12, CADD 22.80
- A138T (p.Ala138Thr), ExAC rs769377888, TOPMed rs769377888, gnomAD rs769377888, REVEL 0.10, CADD 23.30
- A138V (p.Ala138Val), TOPMed rs1725002240, REVEL 0.20, CADD 26.30
- E139K (p.Glu139Lys), 1000Genomes rs545199285, ExAC rs545199285, TOPMed rs545199285, gnomAD rs545199285, REVEL 0.26, CADD 27.90
- P141L (p.Pro141Leu), ESP rs377698107, ExAC rs377698107, TOPMed rs377698107, gnomAD rs377698107, REVEL 0.22, CADD 24.20
- P141S (p.Pro141Ser), NCI-TCGA Cosmic COSV5353, cosmic curated COSV53533, MetaLR 0.20, MetaSVM -0.83, Variant assessed as somatic; moderate impact.
- K145T (p.Lys145Thr), TOPMed rs1724635362, MetaLR 0.13, MetaSVM -1.03
- K146R (p.Lys146Arg), NCI-TCGA TCGA novel, MetaLR 0.38, MetaSVM -0.23, Variant assessed as somatic; moderate impact.
- A150V (p.Ala150Val), gnomAD rs1724633641, REVEL 0.34, CADD 28.60
- P151S (p.Pro151Ser), gnomAD rs1403483347, REVEL 0.38, CADD 26.30
- A152T (p.Ala152Thr), gnomAD rs867454398, REVEL 0.24, CADD 25.30
- N153K (p.Asn153Lys), NCI-TCGA TCGA novel, REVEL 0.17, CADD 23.60, Variant assessed as somatic; moderate impact.
- L156V (p.Leu156Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Y158C (p.Tyr158Cys), TOPMed rs1226020548, gnomAD rs1226020548, REVEL 0.30, CADD 24.80, Uncertain significance, not specified
- N159D (p.Asn159Asp), rs372840138, ESP rs372840138, ExAC rs372840138, TOPMed rs372840138, REVEL 0.08, CADD 23.50, Variant assessed as somatic; moderate impact.
- E160D (p.Glu160Asp), ExAC rs748420211, gnomAD rs748420211, REVEL 0.15, CADD 23.30
- C161R (p.Cys161Arg), NCI-TCGA Cosmic COSV5352, cosmic curated COSV53526, Variant assessed as somatic; moderate impact.
- S162G (p.Ser162Gly), TOPMed rs1724627231, MetaLR 0.03, MetaSVM -1.05
- S162N (p.Ser162Asn), TOPMed rs943455390, gnomAD rs943455390, REVEL 0.14, CADD 19.50
- G163S (p.Gly163Ser), rs1166778125, gnomAD rs1166778125, REVEL 0.22, CADD 25.50, Variant assessed as somatic; moderate impact.
- L164F (p.Leu164Phe), gnomAD rs1475567101, REVEL 0.04, CADD 17.50
- L164H (p.Leu164His), gnomAD rs1425311644
- L164P (p.Leu164Pro), gnomAD rs1425311644
- S165G (p.Ser165Gly), TOPMed rs1197100336, gnomAD rs1197100336, REVEL 0.07, CADD 21.50
- S165N (p.Ser165Asn), TOPMed rs542146598, MetaLR 0.06, MetaSVM -1.15
- S165T (p.Ser165Thr), TOPMed rs542146598, REVEL 0.12, CADD 18.40
- T166N (p.Thr166Asn), gnomAD rs1269539071, REVEL 0.23, CADD 23.20
- Q167H (p.Gln167His), NCI-TCGA Cosmic COSV5352, cosmic curated COSV53527, Variant assessed as somatic; moderate impact.
Public PPARGC1A analysis runs
- PPARGC1A analysis run — PPARGC1A (1,146 variants) — completed 2026-08-20